Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Shaheen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shagufta Shaheen is a medical oncologist based in Palo Alto, CA. Her education includes a residency in Internal Medicine from Ascension Illinois/Saint Joseph, a medical degree from M.G.M. Medical College, and a fellowship in Hematology and Medical Oncology from Loma Linda University Health Education Consortium. She has made significant contributions to the field through her research, leading to multiple publications in notable journals like Clinical Nuclear Medicine, The Oncologist, Journal of the National Comprehensive Cancer Network and Current Treatment Options in Oncology - the importance of her research is highlighted by the number of times her works have been cited by other professionals in the field.
Education & Training
Loma Linda University Health Education ConsortiumFellowship, Hematology and Medical Oncology, 2015 - 2018
Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 2007 - 2010
M.G.M. Medical CollegeClass of 2003
Certifications & Licensure
CA State Medical License 2014 - 2028
MA State Medical License 2010 - 2021
IL State Medical License 2007 - 2011
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- First Autopsy-confirmed Complete Remission of Metastatic Neuroendocrine Neoplasm of Tailgut Cyst After a Single Cycle of Alpha-Peptide Receptor Radionuclide Therapy Wi...Elisabetta Perrone, Shagufta Shaheen, Pamela L Kunz, Heather C Henri, Richard P Baum
Clinical Nuclear Medicine. 2026-07-01 - [Lu]Lu-dota-tate radioligand therapy for advanced pancreatic neuroendocrine tumours.Thorvardur R Halfdanarson, Shagufta Shaheen
The Lancet. Oncology. 2026-06-01 - Mammary small cell neuroendocrine carcinomas that showed excellent pathologic response following etoposide-based neoadjuvant chemotherapy.Phoebe M Hammer, Sheila Enamandram, Debra M Ikeda, Maggie M Lam, Irene L Wapnir
Breast Cancer Research and Treatment. 2025-11-21
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
